Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2007 Nov 15;1:13. doi: 10.1186/1753-2000-1-13

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2007 Schlander; licensee BioMed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Range of plausible projections: expenditures under extreme case scenarios, 2001–2012. a, b: "High Extreme" Case; c, d: Base Case modified "LisDEX without clinical advantage over MPH-MR"; e, f: "Low Extreme" Case; left: England; right: Germany. MPH: methylphenidate; IR: immediate-release formulations (Ritalin^R, branded generics [Equasym^R, Medikinet^R], generics; Focalin^R); MR: modified-release formulations (Concerta^RXL, Equasym^RXL, Medikinet^Rretard, Focalin^RXR; MPH-Patch: transdermal system (Daytrana^R); LisDEX: lisdexamphetamine (NRP104); Nonstimulants: ATX, atomoxetine (Strattera^R), ARM, armodafinil (Sparlon^R); DEX: dexamphetamine (England only).